Keywords: حداکثر غلظت سرمی; Clinical trial; Pilot; Training concept; Pharmacokinetic; Pharmacodynamic; Feasibility; ACE; Angiotensin-converting-enzyme; Cmax; maximum serum concentration; ELISA; Enzyme-linked immunosorbent assay; EMA; European Medicines Agency; EU; European Union; FD
مقالات ISI حداکثر غلظت سرمی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: حداکثر غلظت سرمی; TB; tuberculosis; HIV; human immunodeficiency virus; DPI; dry powder inhaler; AIDS; acquired immunodeficiency syndrome; WHO; world health organization; Mtb; Mycobacterium tuberculosis; AM; alveolar macrophage; PTB; pulmonary TB; EPTB; extra pulmonary TB;
Keywords: حداکثر غلظت سرمی; Antibiotic drug resistance; Caenorhabditis elegans; Methicillin-resistant Staphylococcus aureus; MRSA; Intracellular infection; Pharmacokinetics; AMR; Antimicrobial resistance; Caco-2; heterogeneous human epithelial colorectal adenocarcinoma cells; CFUs;
Nonclinical assessments of the potential biosimilar PF-06439535 and bevacizumab
Keywords: حداکثر غلظت سرمی; Bevacizumab; PF-06439535; Biosimilar; Vascular endothelial growth factor; Nonclinical; Cynomolgus monkey; Sprague Dawley rat; ADA; antidrug antibody; AUC; area under the serum concentration-time curve; AUC0-72; area under the serum concentration-time
Pharmacoscintigraphy studies to assess the feasibility of a controlled release formulation of ziprasidone
Keywords: حداکثر غلظت سرمی; AUCinf; area under the serum concentration-time profile from time 0 extrapolated to infinite time; BA; bioavailability; Cmax; maximum serum concentration; Tmax; time for Cmax; SCT; swellable core technology; CCSD; coated crystals made by spray drying; IR;
Mechanisms and latest clinical studies of new NK1 receptor antagonists for chemotherapy-induced nausea and vomiting: Rolapitant and NEPA (netupitant/palonosetron)
Keywords: حداکثر غلظت سرمی; AE; adverse event; AUC; area under the curve; 5-HT3; serotonin subtype 3; CINV; chemotherapy-induced nausea/vomiting; Cmax; maximum serum concentration; CNS; central nervous system; CR; complete response; CYP; cytochrome P450; ECG; electrocardiogram; FLIE
Current knowledge and pharmacological profile of berberine: An update
Keywords: حداکثر غلظت سرمی; 5-HT; 5-hydroxytryptamine; 6-OHDA; 6-hydroxydopamine; AChE; acetylcholinesterase; AD; Alzheimer's disease; AMPK; AMP-activated protein kinase; BBB; blood brain barrier; BChE; butyrylcholinestesrase; CD; cluster of differentiation; Cdk; cyclin-dependent ki
Peginterferon Pharmacokinetics in African American and Caucasian American Patients With Hepatitis C Virus Genotype 1 Infection
Keywords: حداکثر غلظت سرمی; AA; African American(s); AUC; area under the serum concentration-time curve; BMI; body mass index; CA; Caucasian American(s); CI; confidence interval; Cmax; maximum serum concentration; Cmin; minimum or trough serum concentration; EVR; early virologic res
UDP-glucuronosyltransferases and clinical drug-drug interactions
Keywords: حداکثر غلظت سرمی; UDP-glucuronosyltransferase; UGT1A; UGT2A; UGT2B; Glucuronidation; Drug interaction; Aet-ss; the amount of total drug excreted in urine during one dosage interval; AUCi; area under the plasma concentration-time curve in the presence of an inhibitor; AUC;